Who
Jonathan Wygant
VP, Chief Accounting Officer
Company insider
Files Form 4 as: VP, Chief Accounting Officer, Veracyte; VP, Controller, CAO, Alere; SVP, Chief Accounting Officer, Carefusion.
In numbers
- Trades disclosed
- 75
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $3.0M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 15 Aug 2013
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $61K1,361 at $44.88 | filing |
| 2 Sep 2026filed 4 Sep 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $61K1,361 at $44.88 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $65K1,361 at $47.80 | filing |
| 2 Jun 2026filed 4 Jun 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $65K1,361 at $47.80 | filing |
| 22 May 2026filed 27 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $595K24,000 at $24.80 | filing |
| 22 May 2026filed 27 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $1.1M24,000 at $45.40 | filing |
| 22 May 2026filed 27 May 2026 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —24,000 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | VCYT Veracyteoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —24,000 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code M | $595K24,000 at $24.80 | filing |
| 22 May 2026filed 27 May 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $1.1M24,000 at $45.40 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —10,525 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —10,525 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $108K3,006 at $36.01 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $108K3,006 at $36.01 | filing |
| 2 Dec 2025filed 4 Dec 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $61K1,325 at $46.16 | filing |
| 10 Nov 2025filed 12 Nov 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $216K5,102 at $42.33 | filing |
| 7 Nov 2025filed 12 Nov 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Sold | $234K5,818 at $40.21 | filing |
| 28 Oct 2025filed 30 Oct 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code A | —2,886 at $0.00 | filing |
| 2 Sep 2025filed 4 Sep 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $50K1,648 at $30.11 | filing |
| 2 Jun 2025filed 4 Jun 2025 | VCYT VeracyteDiagnostics & Labs | SEC FORM 4 Code F | $49K1,848 at $26.74 | filing |
News
No headline names them, or the companies they trade most, lately.